Loening SA - Search Results

1

[Tumor suppressor RECK in prostate carcinoma. Decreased RECK expression as indicator of proteolytic imbalance].

Rabien A, Jung M, Fritzsche F, Loening SA, Kristiansen G, Jung K. Rabien A, et al. Among authors: loening sa. Urologe A. 2007 Sep;46(9):1081-2. doi: 10.1007/s00120-007-1434-2. Urologe A. 2007. PMID: 17628776 German. No abstract available.

2

[Quantifying gene expression in prostate carcinoma. Which endogenous reference genes are suitable?].

Jung M, Ohl F, Stephan C, Rabien A, Kristiansen G, Radonić A, Loening SA, Jung K. Jung M, et al. Among authors: loening sa. Urologe A. 2007 Sep;46(9):1083-4. doi: 10.1007/s00120-007-1436-0. Urologe A. 2007. PMID: 17628775 German. No abstract available.

3

[New serum markers in prostate carcinoma and their application to artificial neural networks].

Stephan C, Jung K, Cammann H, Kramer J, Kristiansen G, Loening SA, Lein M. Stephan C, et al. Among authors: loening sa. Urologe A. 2007 Sep;46(9):1084-6. doi: 10.1007/s00120-007-1435-1. Urologe A. 2007. PMID: 17641867 German. No abstract available.

4

Decreased RECK expression indicating proteolytic imbalance in prostate cancer is associated with higher tumor aggressiveness and risk of prostate-specific antigen relapse after radical prostatectomy.

Rabien A, Burkhardt M, Jung M, Fritzsche F, Ringsdorf M, Schicktanz H, Loening SA, Kristiansen G, Jung K. Rabien A, et al. Among authors: loening sa. Eur Urol. 2007 May;51(5):1259-66. doi: 10.1016/j.eururo.2006.05.050. Epub 2006 Jun 14. Eur Urol. 2007. PMID: 16806661

5

[Metalloproteinases (MMP-1, MMP-3) and their inhibitors (TIMP) in blood plasma of patients with prostate carcinoma].

Lein M, Nowak L, Jung K, Koenig F, Schnorr D, Loening SA. Lein M, et al. Among authors: loening sa. Urologe A. 1998 Jul;37(4):377-81. doi: 10.1007/s001200050194. Urologe A. 1998. PMID: 9738289 German.

6

[Molecular forms of prostate-specific antigen and human kallikrein 2 as possible indicators in prostatic carcinoma diagnosis].

Lein M, Stephan C, Jung K, Schnorr D, Loening SA. Lein M, et al. Among authors: loening sa. Urologe A. 2000 Jul;39(4):313-23. doi: 10.1007/s001200050363. Urologe A. 2000. PMID: 10957772 Review. German.

7

[Tumor M2 pyruvate kinase in renal cell carcinoma. Studies of plasma in patients].

Roigas J, Schulze G, Raytarowski S, Jung K, Schnorr D, Loening SA. Roigas J, et al. Among authors: loening sa. Urologe A. 2000 Nov;39(6):554-6. doi: 10.1007/s001200050410. Urologe A. 2000. PMID: 11138278 German.

8

[An artificial neural network as a tool in risk evaluation of prostate cancer. Indication for biopsy with the PSA range of 2-20 microg/l].

Stephan C, Vogel B, Cammann H, Lein M, Klevecka V, Sinha P, Kristiansen G, Schnorr D, Jung K, Loening SA. Stephan C, et al. Among authors: loening sa. Urologe A. 2003 Sep;42(9):1221-9. doi: 10.1007/s00120-003-0322-7. Epub 2003 Mar 22. Urologe A. 2003. PMID: 14504755 Clinical Trial. German.

9

[New serum markers of bone metastasis in prostate carcinoma].

Lein M, Ramankulov A, Stephan C, Kramer J, Loening SA, Jung K. Lein M, et al. Among authors: loening sa. Urologe A. 2007 Sep;46(9):1087-8. doi: 10.1007/s00120-007-1437-z. Urologe A. 2007. PMID: 17628774 German. No abstract available.

10

Increased CD59 protein expression predicts a PSA relapse in patients after radical prostatectomy.

Xu C, Jung M, Burkhardt M, Stephan C, Schnorr D, Loening S, Jung K, Dietel M, Kristiansen G. Xu C, et al. Prostate. 2005 Feb 15;62(3):224-32. doi: 10.1002/pros.20134. Prostate. 2005. PMID: 15389793

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

350 results

Search Page

Filters